Inhibition of Co-Stimulation in Rheumatoid Arthritis
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to use abatacept as a clinical molecular probe to evaluate the
effects of inhibiting costimulation on immune responses in patients with rheumatoid arthritis
(RA).